Aminosalicylate sodium and Cobal

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.

Limited data suggest that aminosalicylic acid may decrease the gastrointestinal absorption of vitamin B12. This interaction is not proven, but is theoretically possible due to a mild malabsorption syndrome that can occur in some patients treated with aminosalicylic acid. However, it should rarely lead to clinically significant deficiency because the body (primarily the liver) usually has a copious supply of vitamin B12 that can sustain a person for several years in the absence of adequate intake. As for the treatment of B12 deficiency-related anemia, non-oral routes of administration (e.g., parenteral, intranasal, sublingual) are generally preferred, which would bypass the potential interaction.

Aminosalicylate sodium

Generic Name: aminosalicylic acid

Brand name: Paser

Synonyms: Aminosalicylate sodium (Oral)

What is Aminosalicylate sodium?

Cobal

Generic Name: cyanocobalamin

Brand name: Cobal 1000, Cobolin-M, Depo-Cobolin, Vitamin B12, B-12 Dots, Nascobal, Vitamin B-12

Synonyms: Cobal 1000

What is Cobal?